{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:22:52Z","timestamp":1791339772973,"version":"4.3.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1926,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-97849"],"award-info":[{"award-number":["MOP-97849"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL081588"],"award-info":[{"award-number":["HL081588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000152","name":"Canadian Hemophilia Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/jth.13749","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T11:42:49Z","timestamp":1496662969000},"page":"1607-1619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice"],"prefix":"10.1016","volume":"15","author":[{"given":"L.L.","family":"Swystun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mewburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deforest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Notley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13749_bb0010","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function","volume":"92","author":"Lenting","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj2570679","article-title":"The interaction between human blood\u2010coagulation factor VIII and von Willebrand factor","volume":"257","author":"Leyte","year":"1989","journal-title":"Biochem J"},{"key":"10.1111\/jth.13749_bb0020","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood.V85.11.3150.bloodjournal85113150","article-title":"The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor","volume":"85","author":"Vlot","year":"1995","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"Fischer","year":"1996","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13749_bb0030","first-page":"289","article-title":"A mathematical model of coagulation factor VIII kinetics","volume":"26","author":"Noe","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/jth.13749_bb0035","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI113721","article-title":"Inactivation of human factor VIII by activated protein C","volume":"82","author":"Koedam","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13749_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V93.1.193","article-title":"von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver","volume":"93","author":"Kaufman","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor","volume":"60","author":"Weiss","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13749_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1982.tb03888.x","article-title":"Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease","volume":"52","author":"Tuddenham","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13749_bb0055","first-page":"270","article-title":"Pharmacokinetics of monoclonally\u2010purified and recombinant factor VIII in patients with severe von Willebrand disease","volume":"2","author":"Morfini","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13749_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/jth.13749_bb0070","first-page":"337","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Clin Haematol"},{"key":"10.1111\/jth.13749_bb0075","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1111\/hae.12733","article-title":"Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype","volume":"21","author":"van Meegeren","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13749_bb0080","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V96.3.958","article-title":"A novel cause of mild\/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor","volume":"96","author":"Jacquemin","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/asheducation.V2014.1.531.3883265","article-title":"New insights into genotype and phenotype of VWD","volume":"2014","author":"Flood","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1111\/jth.13749_bb0090","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1016\/S0021-9258(18)54972-3","article-title":"Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease","volume":"266","author":"Kroner","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13749_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V79.3.563.563","article-title":"The mutation Arg (53) \u2010> Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor","volume":"79","author":"Jorieux","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0100","first-page":"290","article-title":"Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide","volume":"3","author":"Hilbert","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13749_bb0105","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1016\/S0021-9258(18)54729-3","article-title":"The role of von Willebrand Factor multimers and propeptide cleavage in binding and stabilization of factor VIII","volume":"266","author":"Wise","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13749_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.12019","article-title":"Establishment and characterization of a new and stable collagen\u2010binding assay for the assessment of von Willebrand factor activity","volume":"35","author":"Ni","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13749_bb0115","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13749_bb0120","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0125","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation\u2010specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2011-09-381400","article-title":"In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling","volume":"119","author":"Nishimura","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/hae.12907","article-title":"Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice \u2013 characterization of two novel FVIII molecules","volume":"22","author":"Johansen","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13749_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0145","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13749_bb0150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2015-04-641696","article-title":"Visualization of an N\u2010terminal fragment of von Willebrand factor in complex with factor VIII","volume":"126","author":"Yee","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0155","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2015-04-641688","article-title":"Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry","volume":"126","author":"Chiu","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0160","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2013-07-517086","article-title":"Solution structure of the major factor VIII binding region on von Willebrand factor","volume":"123","author":"Shiltagh","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0165","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1016\/S0021-9258(18)92725-0","article-title":"Molecular characterization of a unique von Willebrand disease variant","volume":"266","author":"Cacheris","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13749_bb0170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1991.tb04480.x","article-title":"Identification of two point mutations in the von Willebrand factor gene of three families with the \u201cNormandy\u201d variant of von Willebrand disease","volume":"78","author":"Gaucher","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13749_bb0175","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/j.1538-7836.2010.03971.x","article-title":"Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype","volume":"8","author":"Castaman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13749_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2141.2004.05187.x","article-title":"Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene","volume":"127","author":"Hilbert","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13749_bb0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0190","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","article-title":"Recessive inheritance of von Willebrand's disease type I haplotype analysis","volume":"341","author":"Eikenboom","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/jth.13749_bb0195","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease\u202f: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI1250","article-title":"Intracellular trafficking of factor VIII to von Willebrand factor storage granules","volume":"101","author":"Rosenberg","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13749_bb0205","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0210","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2008-05-159699","article-title":"Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles","volume":"113","author":"Van Biggelaar","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0215","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease\u2010causing variants of von Willebrand factor","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MBC.0000000000000635","article-title":"Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients","author":"Selvam","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13749_bb0225","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V95.10.3139","article-title":"Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment","volume":"95","author":"Jorieux","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0230","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization","volume":"92","author":"Jorieux","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0235","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease\u2010causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2016.08.009","article-title":"Mutations in the D'D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWF","volume":"145","author":"White\u2010Adams","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13749_bb0245","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2015-01-620245","article-title":"Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine","volume":"126","author":"Gilbert","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0250","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/hq0302.105359","article-title":"Phospholipid\u2010binding domain of factor VIII is involved in endothelial cell\u2010mediated activation of factor X by factor IXa","volume":"22","author":"Brinkman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13749_bb0255","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0037-1614471","article-title":"A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic","volume":"81","author":"Kawasaki","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13749_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1160\/TH12-05-0316","article-title":"In vitro and in vivo evaluation of the effect of elevated factor VIII on the thrombogenic process","volume":"109","author":"Golder","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13749_bb0265","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2008-04-152959","article-title":"Analysis of the spatial and temporal characteristics of platelet\u2010delivered factor VIII\u2010based clots","volume":"112","author":"Neyman","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0270","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1111\/j.1365-2516.2009.02133.x","article-title":"A ferric chloride induced arterial injury model used as haemostatic effect model","volume":"16","author":"M\u00f8ller","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13749_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2008-02-142943","article-title":"Altered thrombus formation in von Willebrand factor\u2010deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa","volume":"112","author":"Marx","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0280","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood-2013-09-521484","article-title":"Analysis of the role of von Willebrand factor, platelet glycoprotein VI\u2010, and \u03b12\u03b21\u2010mediated collagen binding in thrombus formation","volume":"124","author":"Shida","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0285","first-page":"22","article-title":"Von Willebrand factor is indispensable for venous hemostasis in a novel murine bleeding model","volume":"13","author":"Bazaa","year":"2015","journal-title":"J Thromb Haem"},{"key":"10.1111\/jth.13749_bb0290","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2006-06-028241","article-title":"von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0295","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2011-06-362814","article-title":"Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice","volume":"118","author":"Machlus","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13749_bb0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood-2015-12-684688","article-title":"Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo","volume":"128","author":"Pan","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13749\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:19:08Z","timestamp":1761535148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622043380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1538783622043380"],"URL":"https:\/\/doi.org\/10.1111\/jth.13749","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}